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Abstract 
Glycated hemoglobins (HbAiiHbAic) serves as an indicator of diabetic control and 
hence the effectiveness of treatment. Studies on the methods available have shown that 
factors such as hemoglobin concentration and the presence of high lipid in the blood may 
affect the validity of the results. Atypical hemoglobins such as HbS and HbC have also 
been shown to affect the determination of glycated hemoglobins. However no study has 
been done on the effect of HbE , the hemoglobin variant that is present in the South East 
Asian population. Thus this study was unde~ to determine the effect of HbE on fu~ 
-determination ofHbAI/HbAlc by 4 commercial kits and also to determine its prevalence 
among diabetic subjects in Kelantan. 
Blood was taken from 58 normal subjects (23 males and 35 females) and 63 HbE (31 
males and 32 females) heterozygous subjects. All subjects ,bad no history of diabetes 
mellitus. They had random blood glucose values < 7.8 mmolll and hemoglobin (hb) 
values between 7 to 24 g/dl. The EDTA plasma collected were tested for HbAI and 
HbAlc using 4 commercial kits i.e. Eagles Diagnostics, Boehringer Mannheim (BM), 
Diastat and Ames DCA 2000. The tests were done within one week and samples were 
stored at 4 oc before analysis. 
Results showed that the mean± s.d HbAI levels in normal vs HbE heterozygous subjects 
using Eagles Diagnostics, Boehringer Mannheim and Diastat kits were 6.9 ± 1.1% vs 9.5 
± 3.9%; 7.1 ± 1.2% vs 14.8 ± 9.3% and 8.3 ± 3.8% vs 13.5 ± 10.8% respectively. All 
were significantly different (p<O.OOI). The mean± s.d HbAlc levels for normal vs HbE 
heterozygous subjects determined using Ames DCA 2000 and Diastat kits were 5.1 ± 
0.5% vs 5.3 ± 2.7% and 6.1 ±.).9% vs 10.7 ± 8.7% respectively. The results measured 
using the Diastat kit were significantly different (p<0.001) while those measured using 
the Ames DCA 2000 kit were not significantly different (p = 0.5). 
Therefore the cation-exchange chromatography based kits (Eagles Diagnostic, 
7 . 
Boehringer Mannheim and Diastat) were affected by the presence of HbE. This 
-interference was minimised by dilution. The use of~pecific antibody (Ames) did not have 
any influence on HbA 1 c determination. 
The prevalence of HbE among diabetics were also studied. Blood was taken from 202 
diabetic patients (121 females and 81 males; aged 46.2 ± 15.2 years) who were attending 
the outpatient diabetes clinic, Hospital USM. 28 patients (13.9%) were confirmed to 
carry HbE by hemoglobin electrophoresis. This consists of 4 males and 24 females. The 
finding is consistent with the prevalence ofHbE heterozygotes in the general population. 
In conclusio~ this study showed that HbE affect the determination ofHbAl/HbAlc by 
kits using cation exchange chromatography and that the interference may be diluted out 
The prevalence of HbE among diabetes mellitus patients is similar to that of the general 
population. 
1.0 INTRODUCTION 
Glycated hemoglobins are foimed during a non-enzymatic reaction when glucose 
attaches itself to the N-terminus of the 13- chain of hemoglobin Ao( 1 ). The level of 
glycated hemoglobins is proportional to the level of blood glucose over a period of two 
months (2). Thus glycated hemoglobins are accepted as an indicator of hood glucose 
level over the preceeding two months. 
.. 
The commonly measured glycated hemoglobins for monitoring diabetic control are 
--
hemoglobin Al (HbAl) or its subfraction hemoglo~in Ale (HbAlc). Using these levels, 
treatment are adjusted to achieve good metabolic control in diabetic patients. 
Most of the commercially available kits for the determination of HbAl or HbAlc use 
cation-exchange chromatography technique - although the use of specific antibody 
against the J3-chain has gained popularity. The use of cation-exchange chromatography 
based kits will still be popular locally as it is simple to perform and cheap, costing about 
a quarter to half the price of an immunoassay based kit. 
Measurements of HbAl or HbAlc involve separating these from the other hemoglobin 
fractions by either the use of electrophoresis, cation-exchange chromatography or 
specific antibody. The value is then reported as a percentage of the total hemoglobin. 
Normal HbAI levels for non-diabetic subjects had been reported as 6 - 8 %while for 
HbA1c it is 3-6% (3.4.5). 
Thus the accuracy of the results obtained is affected by the total hemoglobin 
concentration and the level of inaccuracies varies with each kit. The same is true 
regarding the influence of hemoglobin variants. The manufacturers reported that atypical 
hemoglobins such as HbS, HbC and HbF co-elute with HbA 1 or HbA 1 c during cation-
exchange chromatography resulting in higher HbA 1 or HbA I c values respectively 
7 ....... 
(6,7,8). The influence of these variant hemoglobins were not seen in methods employing 
_,. -·~ ,:ta 
specific antibody (9). Although extensive studies were done on the effect of HbS, HbC 
and HbF, no study was done to determine the influence of HbE on the validity of HbAI 
or HbAlc measurements. HbE is an atypical hemoglobin, more commonly present in the 
South East Asian population than the western population. In the North East region of 
Peninsular Malaysia, 13 % of the population was observed to be HbE heterozygotes and 
3% were clinically symptomatic homozygous (10). 
The presence of HbE was observed to affect the total hemoglobin concentration by 
masking anemia (10). Thus, because the HbAl or HbAlc levels are reported as a 
percentage of total hemoglobins, the presence of HbE might affect the validity of HbA 1 
or HbAlc results. Further, HbE might behave exactly like HbS or HbC by co-eluting with 
HbAl or HbAlc during cation-exchange chromatography. 
Thus in this study, the effect of HbE on 4 commercial kits were studied. Three of the kits 
used employed cation-exchange chromatography technique while the other kit is the 
more expensive based on the use of specific antibody. This is necessary as the results 
obtained during this study will be used to choose the most suitable method to routinely 
monitor the diabetic control of our patients. 
The prevalence of HbE among diabetes mellitus was also studied. This is necessary so .-:: 
that the extent of the problem in monitori~g diabetes control VIa HbAl/HbAl~ 
measurements could be gauged and appropriate actions be taken. 
1.1 AIM 
1. To study the effect ofHbE on the determination ofHbAl and HbAlc by 4 
commercial kits; 
2. To determine ways to reduce the above effect; 
3. To determine the prevalence of HbE among diabetes mellitus patients 
2.0 MATERIALS AND METHODS 
2.1 MATERIALS 
I. Diastat hemoglobin kit, cat. no. 210-0002, Bio-Rad Laboratories, USA. 
- A fully automated low pressure cation exchange column c~omatoraphy method 
using gradient elution to separate human hemoglobin subtypes and variants from 
hemolysed whole blood. Measures both HbA1 and HbAlc. 
n. Hemoglobin AI kit, cat. no. 575453, Boehringer Mannheim GmbH, Germany. 
/., 
- A manual low pressure cation exchange column. chromatography method. 
--~ ..... 
Measures HbAl. 
111. Glycohemoglobin, cat no. GH-1 00, Eagles Diagnostics, USA. 
A manual cation-exchange resin method. Measures HbA1. 
tv. Ames DCA 2000 HbA1c ragent kit, cat no 5036, Bayer Diagnostics, UK. 
- A fully automated cartridge style kit using specific aritibody to the glycated 
amino-terminal residues of the 13-chain of HbA. Measures HbA 1 c. 
v. Accutrend glucose, cat no. 07786, Boehringer Mannheim, Germany. 
VI. Hb electrophoresis kit, cat. no. 441780, Beckmann, UK. 
vtt. Anticoagulant K2 EDTA for 2.5ml blood, cat no 113337, LP, Italy . 
. • 
viii. Isolab hemocard hb FAE control, HE 1580. 
ix. Isolab Hb AlE control, HEC-901 
x. 1.5ml tube with cap, Eppendorf 
xi. Sterile syringes and needles, 10 cc, 21 Gx! 1/2, Becton Dickinson, USA. 
2.2. SUBJECTS 
2.2.1. NORMAL SUBJECTS 
Blood was taken from volunteers and tested immediately for random blood glucose 
(RBS) (Accutrend, Boehringer Mannheim, Germany) and full blood picture (FBP). All 
volunteer subjects have no history of diabetes mellitus. Only those with RBS values less 
than 7.8 mmol/1 and normal FBP were included in this study. 
- • .. 4 
-· Complete data were obtained from 58 subjects consisting of 23 males and 35 females. 
The mean age ± s.d. was 24 ± 8.2 years (range 17 - 47 years). Their random blood 
glucose level (RBS) was 5.1 ± 1.1 mmol/1 (3.6 - 7.8 mmol/1) and hemoglobin (hb) was 
13.8 ± 0.7 g/dl (10.6- 16.6 g/dl). 
2.2.2 . THALASSAEMIC SUBJECTS 
103 blood samples with 'thalassaemic FBP' profile were confirmed for the presence of 
HbE using Hb electrophoresis (Beckmann, USA). All patients had no history of diabetes 
mellitus. The RBS and hb were also measured and noted Only those with RBS levels of 
<7.8 mmol/1 and hb 7- 24 g/dl were included in the study. 
Complete data were obtained from 63 subjects (31 males and 32 females). Their mean± 
s.d. age was 23.6 ± 15.6 years ( 1- 64 years). Their RBS level was 4.3_± 1.3 mmol/1 (3.4-
7.4 mmoVI) and the hb level was 10.8 ± 2.1 gldl (7.2- 15.6 g/dl). 
2.2.3. DIABETIC SUBJECTS 
284 diabetes mellitus patients who were attending the diabetes outpatient clinic at 
Hospital USM were screened for urine sugar, RBS, FBP and HbA1 (Eagles Diagnostic, 
USA). Those with 'thalassaemic FBP' profile were tested further with hb electrophoresis 
.7 
to confirm the presence of HbE. 
,.,. 
Complete data were obtained from 202 patients - 121 females and 81 males. The mean ± 
s.d. age was 46.2 ± 15.2 years, ( 6 - 78 years ), hb level was 12.6 _± 2.3 g/dl ( 7.4 - 17.4 
g/dl) and RBS was 9.1 ± 5.6 mmoVl (3.2- 25.4 mmoVI). 
2.3 METHODS 
2.3.1 EVALUATION OF KITS 
The performance for each of the kits were evaluated in terms of its intra- and inter day 
precisions using quality control samples at normal and elevated levels (Eagles 
Diagnostics, USA). 
2.3.2 EVALUATION OF STORAGE CONDITION FOR THE SAMPLES 
Pooled plasma samples from normal (normal level) and diabetic subjects (elevated level) 
were analysed for HbAl using ·Eagles Diagnostic kit (USA). The samples were then 
divided into aliquots of200 ul and stored at 3 temperatures i.e. room temperature (25°C), 
4°C and -20°C. Aliqouts were taken, thawed (if necessary) and analysed for HbAl using 
Eagles Diagnostic kit (USA) daily until day 25. 
2.3.3. EFFECT OF HbE ON THE DETERMINATION OF HbAl/HbAlc 
-~ .... 
Each EDTA plasma samples from normal subjects and HbE positive subjects were 
-
analysed for HbAl and/or HbAlc using Dias~t, Boehringer Mannheim, Eagles 
Diagnostic and Ames DCA 2000 kits. The plasma samples were stored at 4 oc before 
analysis. All the HbAl/HbAlc determinations on each sample were done within 1 week. 
~ ..,.... 
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The mean HbAl and HbAlc levels± s.d were then calculated for the normal and the 
~-~· 
HbE heterozygous groups. The results were then statistically compared using Student's t-
test (Microsoft Excel, USA). 
-~--
2.3.3.1. Effect of diluting Hbe positive samples 
EDTA plasma samples from normal subjects were pooled and the HbAliHbAlc levels 
determined using the 4 commercial kits. This was then used to dilute HbE positive 
samples by 1:2 and 1:4 dilutions . The HbA1/HbAlc levels of the neat and the diluted 
. ·-
to;!;. 
•' 
.! 
samples were then measured Actual HbAl/HbA 1 c levels obtained by measurement were 
then compared with the calculated or expected values. 
2.3.4. PREVALENCE OF HbE AMONG DIABETES MELLITUS PATIENTS 
Blood taken from diabetes mellitus patients was tested for RBS and HbAl (Eagles 
Diagnostics) and FBP (Beckman, USA) immediately. Those samples with 'thalassaemic 
FBP'profile were confirmed for HbE on hb electrophoresis. The number and percentage 
of those with HbE was then calculated 
. r:. 
-:::;:· 
~·. 
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3. RESULTS AND DISCUSSION 
3.1. PERFORMANCE OF HbAl AND HbAlc KITS 
Table 1 shows the within-run precision ofHbA1 determinations using Eagles Diagnostic, 
Boehringer Mannheim and Diastat kits and HbA1c determinations using Diastat and 
Ames DCA 2000 kits. 
:. 
Table 1. Intra-day precision of HbAl and HbAlc determinations using Eagles 
·:r 
/ 
Diagnostic(Eagles), Boehringer Mannheim(BM),Dia~tat and Ames DCA 2000 
(Ames) kits. 
EAGLES BM DIASTAT DIASTAT AMES 
HbA1 (%) HbA1 (%) HbA1 (%) HbA1c (%) HbAlc (%) 
mean 7.8 7.9 7.9 5.7 5.2 
s.d 0.2 0.2 0.2 0.1 0.1 
cv 2.7% 2.5% 2.5% 1.8% 2.3% 
n 10 6 6 6 6 
mean 13.4 17.5 20.1 14.8 11.9 
s.d 0.2 1.3 1.2 0.3 0.3 
. 
cv 1.7% 7.4% 6.0% 2.0% 2.8% 
n 10 6 6 6 6 
The coefficient of variations ( cv) of the within-run precision for the normal level is 
below 3% for all the kits tested and agrees to the manufacturers reported range (6,7,8,9). 
However at elevated levels, the HbA 1 values determined by Boehringer Mannheim and 
Diastat kits were high (c.v 7.4 and 6% respectively). 
Table 2. Inter-run precision for HbAl and HbAlc determinations using Eagles 
Diagnostic {Eagles), Boehringer Mannheim (BM), Diastat and Ames DCA 2000 
(Ames) kits. 
bagles .tiM Utastat . U1astat Ames 
~"' ... 
HbAl(%) HbAl(%) HbAl(%) HbAlc(%) HbAlc(%) 
mean 7.2 8.4 7.8 5.8 5.1 
S.d. 0.5 1.0 0.7 0.6 0.1 
cv 6.8% 11.5% 9% 10.3% 1.2% 
n 11 9 12 12' 12 
mean 14.3 17.9 19.3 14.2 11.8 
s.d 0.7 1.5 0.9 1.7 0.1 
cv 5% 8.4% 4.7% 12.0% 0.8% 
n 12 9 12 13 12 
Table 2 shows the interday precision Qf HbAl and HbA1c using the 4 commercial kits 
tested in this study. 
The Ames DCA 2000 kit gave reproducible results as is shown by the low standard 
deviation (s.d) and cv (tables 1 and 2). The worst cv was obtained using the BM and 
Diastat kits. 
Good precisions were obtained using the Ames DCA 2000 kit. This is not surpris~g as 
this is a fully automated cartridge type procedure. Acceptable reproducibility was also 
obtained using the Eagles Diagnostic kit eventhough it is a manual method. However this 
method is used routinely in our laboratory and hence the technologists are skillful in 
.. 
performing this assay. The comparatively poor reproducibilities ofBM kit may be due to· 
lack of experience in handling this manual metho~. However what is surprising is the 
comparatively poor precision obtained with the fully automated cation-exchange column 
chromatography based Diastat kit. This could be due to the instability of the columns or 
the inherent variability and efficiency of the eluting system. 
Thus the fully automated antibody based Ames DCA 2000 kit gave the best within - and 
inter- run precisions. For the cation-exchange chromatography based kits, experience in 
handling as well as the efficiency of the column and its eluting system is important in 
ensuring good reproducibility. 
'• 
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3.2 STABaiTY OF SAMPLES 
Figures 1 and 2 show the stability of samples stored as whole blood or hemolysate under 
various conditions for over 25 days. Figure 1 shows the stability ofHbAl at normal range 
(normal subjects) and Figure 2 shows the stability of HbAl at elevated range (diabetic 
subjects). 
As can be seen from the results, deterioration in the samples caused the results to be 
elevated. 
..., 
,_~i 
From the results, whole blood samples stored as 4°C gave the best stability over 11 day 
period. Thus for this study, samples for HbAl and HbA1c determinations were stored as 
whole blood at 4 °C for a period not exceeding 7 days. 
FIGURE 1: STABILITY OF HbAl NORMAL SAMPLES STORED AS WHOLE 
BLOOD (NH) OR BEMOLYSATE (H) AT 25C, 4C AND -20C. 
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FIGURE 2: STABILITY OF HbAl ELEVATED SAMPLES STORED AS WHOLE 
BLOOD (NH) OR HEMOLYSATE (B) AT 2SC, 4C AND -lOC. 
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3.3 NORMAL HbAl AND HbAlc LEVELS 
Table 3 shows the means± s.d ofHbAl and HbAlc levels for the normal volunteers. 
Table 3: Normal HbAl and HbAlc levels in normal subjects as measured by Eagles 
Diagnostic (Eagles), Boehringer Mannheim (BM), Diastat and Ames DCA 2000 
(Ames) kits. 
Eagles BM Diastat Diastat Ames 
HbAl (%) HbA1 (%) HbAl (%) HbA1c (%) HbAlc (%) 
7 
mean 6.9 7.1 8.3 6.1 5.1 
G 
~· ,-. 
-
s.d 1.1 1.2 3.8 . 1.9 0.5 
n 58 58 58 58 58 
.. 
,.,,-
The nonnal levels obtained in this study agreed with those published in the literature 
(nonnal HbA 1 6 - 8% and HbA 1 c 3 -6 % ). However results obtained with the Diastat kit 
gave a slightly higher value. 
There was no significant difference in HbA 1 and HbA 1 c levels between the sexes again 
.. 
agreeing to earlier observations. 
·~ 
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3.4. EFFECT OF HbE ON THE DETERMINATION OF HbAl AND HbAlc 
Table 4 shows the comparison between the means± s.d ofHbAl and HbAlc in normal 
versus HbE heterozygous subjects as determined by the 4 commercial kits tested in this 
study. 
Table 4: Comparison of the means ± s.d HbAl and HbAlc levels of normal and HbE 
heterozygous subjects as determined using Eagles Diagnostic (Eagles), Boehringer --
Mannheim (BM), Diastat and Ames DCA 2000_(Ames) kits • 
Eagles BM Diastat ··-
•. 
Diastat Ames 
~ 
HbA1 (%) HbAl (%) HbAl (%) HbAlc (%) HbAlc(%) 
normals 6.9 ± 1.1 7.1 ± 1.2 8.3 ±3.8 6.1 ± 1.9 5.1 ± 0.5 
HbE 9.5 ±3.9 14.8 ± 9.3 13.5 ± 10.8 10.7±8.7 5.3 ±2.7 
p value <0.001 <0.001 <0.001 <0.001 0.5 
The results clearly show that there was no significant difference between the means ± s.d 
of HbA 1 c levels of normals and HbE subjects as determined by the Ames DCA 2000 kit. 
Ames DCA 2000 uses antibody that binds to the glycated terminus of the J3-chain while 
HbE involves mutation at point 26. Thus the antibody is able to recognise HbE as well as 
HbAlor HbAlc. 
The cation- exchange chromatography based kits were all affected by the presence of 
HbE (Table 4). l-lbE levels increased the HbAl and HbAlc results determined using the 
Eagles Diagnostics, Boehringer Mannheim and Diastat kits (p<O.OOl). This conclusion 
can also be gathered from Figures 3,4,5,6 ::md 7 \Vhich sho\v L,e dotplot diagrams of 
HbAl and HbAlc levels in nonnal and HbE heterozygous subjects as measured by the 4 
kits tested. 
The interference HbE exerts on the above measurement could be due to 2 factors: HbE 
affecting the total hemoglobin detennination or l]bE co-elutes with the HbA 1 and HbA 1 c 
fractions.HbE was observed earlier to affect the results of total Hb by giving a falsely 
raised value ( 1 0). If this is the main interference, then the HbA 1 or HbA 1 c · results 
Ineasurii!d ·.vould be low. Ho,vever, vve noticed an increased in the level of g1ycated 
hemoglo0in measured using the cation-exchange chromatography based kits. Thus this 
could mean that the co-elution of HbE with the glycated hemoglobin is the predominant 
effect. 
The co-elution \vith HbE on cation-exchange columns is not a strange phenomena. 
Similar observations were noted \vith other hemoglobin variants such as HbS and HbC 
resulting in the raised HbA 1 or HbAlc levels (7). All three kits used low pressure 
chromatography. The use of high performance liquid c~..romatograr:hy or different 
columns such as PolyCAT A (11) might be able to resolve HbE from HbAl or HbAlc. 
Fig. 3: HbAl Levels in Nonnal end h1:if Eeterczygous Subjects as Cete.rrr.ined Using Eagles Diagnostic Kit. 
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Fig. 4: Hb2~.l Levels L'1 r\o.::rnal and HbE Heterozygous Subjects as L:eter.nii'1ed us~""lg 
Eoer~inger Mannheirn Kit. 
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Fig 6: HbAlc Levels in Normal arrl HbE Heterozygous Subjects as Determined 
Using Diastat kit. 
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Fig. 7: Hb.l\lc Levels in Nonnal and HbE re1:etczyg:l.E· subjects as detennined using 
Ames DCA 2000 kit 
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Therefore this study shows that HbE influences the results of HbA 1 and HbA 1 c 
determinations done on cation-exchange chromatography based methods. 
3.4.1. Effect of dilution on the influence of HbE 
Tables 5 and 6'show the results of the dilution studies on HbE samples. 
Table 5: Dilution study on HbE samples: Expected and Actual HbAl values after 
dilution with pooled normal non HbE samples as measured using Eagles Diagnostic 
(Eagles), Boehringer Mannheim (BM), Diastat and Ames DCA 2000 (Ames) kits. 
Dilution Eagles BM Diastat 
Expected Actual Expected Actual Expected Actual 
sample A 
1·1 
·-
7.3 6.3 7.5 6.3 9.3 8.9 
1:4 7.0 6.2 7.2 6.2 8.3 7.9 
sampleB 
1:2 7.9 6.9 8.1 6.6 8.1 6.5 
1:4 7.4 6.1 7.4 6.2 7.6 6.7 
.• 
Table 6: Dilution study of HbE samples: Expected and Actual HbAl values after 
dilution with pooled normal non HbE samples as measured by Eagles Diagnostic 
(Eagles), Boehringer Mannheim (BM), Diastat and Ames DCA 2000 (Ames) kits. 
\c 
Dilution :..~es (%) Dtastat (%) 
Expected Actual Expected Actual 
sampJeA 
. 
.. 
1:2 5.2 5.2 6.~ 6.0 
'• 
1:4 5.2 5.2 5.8 5.4 
samp1eB 
1:2 5.2 5.1 5.9 5.0 
1:4 5.2 5.1 5.7 5.0 
The 'expected' results are the calculated values from the levels of the neat, undiluted 
samples. The 'actual' values are the results observed on measurement. In table 5, each of 
the actual values obtained was infact lower than the expected value. Thus the high HbAl 
level presen~. when measuring the neat sample was infact due to interference. This 
interference was abolished upon dilution. Hence the actual results obtained during 
dilution corresponds more to the normal non diabetic HbAllevels. 
Similar observations were seen with the HbA 1 c determination using the Diastat kit 
(Table 6). HbAlc measurements by the Ames DCA 2000 kit was not affected by the 
presence of HbE in the samples and this is shown by the similarities in the expected and 
actual values obtained after dilution. 
Thus the interference by HbE on HbAl and HbAlc determinations can be overcome by 
dilution of the samples. 
Table 7 shows the percentage ofHbE subjects having HbAl or HbAlc values higher than 
the upper limit of normal (HbA 1 = 8% and HbAl c = 6% ~ 
Table 7: Percent BbE heterozygous subjects with elevated HbAl or BbAlc values 
as determined by Eagles Diagnostic(Eagles), Boehringer Mannheim (BM), Diastat 
and Ames DCA 2000 (Ames) kits. 
Eagles BM Diastat Diastat Ames 
HbAl HbAl HbAl HbAlc HbAlc 
percentHbE 
subjects 
with 38.1 82.0 58.7 74.6 1.6 
elevated 
HbAl or 
HbAlc 
levels 
The results show that considerable number of patients with elevated HbAl and HbAlc 
levels as measured by the cation-exchange based methods. However the worst affected 
was the Boehringer Mannheim manual kit. The importance of the inherent quality of the 
separating system is shown by the fact that the fully automated Diastat system gave 
results worse than the manual Eagles Diagnostic system. Again, the results of Table 7 
showed that the HbAlc levels measured using the Ames DCA 2000 kit were not affected 
by the presence of HbE. Thus it is recommended that samples from HbE heterozygotes 
patients should not be measured by cation exchange chromatography based methods. 
. ~ 
The antibody based procedures are more reliable in giving valid results under this 
condition. However if there is no other choice, then samples from patients with HbE 
should be diluted for the measurement of glycated hemoglobins using cation exchange 
based methods. 
3.5 PREVALENCE OF BbE HETEROZYGOTES AMONG DIABETES 
MELLITUS PATIENTS 
From this study, we found that 28 patients were carriers ofHbE and this was confirmed 
by hb electrophoresis. They constituted 13. 9o/o of the diabetes mellitus patients. Of these, 
4 were males and 24 were females. 
This observation agrees with the earlier observation on the prevalence of HbE among the 
general population (10) . Hence the prevalence of HbE heterozygotes in Diabetes 
Mellitus patients is similar to that of the general population. 
4. CONCLUSION 
This study shows that HbE affects the determination of HbA 1 and HbA 1 c using kits 
based on cation-exchange chromatography with low-pressure system. This could 
principally be due to the co-elution ofHbE with HbAl!HbAlc thus giving falsely raised 
levels. This interference could be abolished by dilution. 
HbE does not affect the determination of HbA 1 c using methods based on specific 
antibody to the glycated terminus of the J3-chain .. Thus it is recommended that for HbE 
positive diabetes mellitus patients, the determination .~f their HbA 1 (or HbA 1 c) should be 
carried out using kits based on specific antibody and not on cation-exchange 
chromatography. 
This study also show that the prevalence of HbE among diabetes mellitus patients is 
similar to that of the general population . 
. • 
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